Novartis pauses trials of experimental cell therapy after three deaths

Novartis NOVN.S said on Tuesday it paused eight clinical trials of an experimental cell therapy, called rap-cel, targeting autoimmune and neurological disorders in late August, after three patients died. The halt was implemented on August 24 after Novartis was notified of three…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Cyprus Mail.